Archives
Showing 121 - 130 of 154 posts
https://www.coltonconsortium.org/publications/chimeric-antigen-receptor-t-cells-against-the-ighv4-34-b-cell-receptor-specifically-eliminate-neoplastic-and-autoimmune-b-cells/
https://www.coltonconsortium.org/publications/clns1a-regulates-genome-stability-and-cell-cycle-progression-to-control-cd4-t-cell-function-and-autoimmunity/
https://www.coltonconsortium.org/publications/a-lupus-derived-autoantibody-that-binds-to-intracellular-rna-activates-cgas-mediated-tumor-immunity-and-can-deliver-rna-into-cells/
https://www.coltonconsortium.org/publications/a-phase-3-trial-of-upadacitinib-for-giant-cell-arteritis/
https://www.coltonconsortium.org/publications/a-randomized-double-blind-placebo-controlled-trial-of-abatacept-for-the-treatment-of-relapsing-non-severe-granulomatosis-with-polyangiitis/
https://www.coltonconsortium.org/publications/agent-based-modeling-for-personalized-prediction-of-an-experimental-immune-response-to-immunotherapeutic-antibodies/
https://www.coltonconsortium.org/publications/an-autoimmune-transcriptional-circuit-drives-foxp3-regulatory-t-cell-dysfunction/
https://www.coltonconsortium.org/publications/chemical-tools-based-on-the-tetrapeptide-sequence-of-il-18-reveals-shared-specificities-between-inflammatory-and-apoptotic-initiator-caspases/
https://www.coltonconsortium.org/news/yale-news-spotlights-the-colton-center-as-a-key-driver-of-autoimmune-innovation-at-yale-ventures/
A Yale News feature on Yale Ventures' five accelerator funds highlights the Colton Center for Autoimmunity's growing role in translating autoimmune research into startups, licenses, and real-world therapies.
https://www.coltonconsortium.org/news/yale-researchers-use-machine-learning-to-improve-personalized-cancer-vaccine-design/
A Colton-supported Yale study has produced ImmunoStruct, a machine learning model that improves personalized cancer vaccine design by incorporating the 3D structure of immune-activating peptides — now licensed to a Yale spinout.
